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Abstract: Equine influenza virus (EIV) is considered the most important respiratory pathogen of
horses as outbreaks of the disease lead to substantial economic losses. The H3N8 EIV has caused
respiratory disease in horses across the world, including South American countries. Nucleotide and
deduced amino acid sequences for the complete haemagglutinin gene of the H3N8 EIV detected in
South America since 1963 were analyzed. Phylogenetic and Bayesian coalescent analyses were carried
out to study the origin, the time of the most recent common ancestors (tMRCA), the demographic and
the phylogeographic patterns of the H3N8 EIV. The phylogenetic analysis demonstrated that the H3N8
EIV detected in South America grouped in 5 well-supported monophyletic clades, each associated
with strains of different origins. The tMRCA estimated for each group suggested that the virus was
circulating in North America at least one year before its effective circulation in the South American
population. Phylogenetic and coalescent analyses revealed a polyphyletic behavior of the viruses
causing the outbreaks in South America between 1963 and 2012, possibly due to the introduction of
at least 4 different EIVs through the international movement of horses. In addition, phylodynamic
analysis suggested South America as the starting point of the spread of the H3N8 EIV in 1963 and
showed migration links from the United States to South America in the subsequent EIV irruptions.
Further, an increase in the relative genetic diversity was observed between 2006 and 2007 and
a subsequent decline since 2009, probably due to the co-circulation of different lineages and as a result
of the incorporation of the Florida clade 2 strain in vaccines, respectively. The observed data highlight
the importance of epidemiological surveillance and the implementation of appropriate quarantine
procedures to prevent outbreaks of the disease.
Keywords: equine influenza; South America; haemagglutinin; phylodynamics; phylogeography
1. Introduction
Equine influenza (EI) is one of the major infectious respiratory diseases of horses and is considered
severely damaging in economic terms. This is due to the highly contagious nature of the virus which
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facilitates rapid spread among susceptible horses, with the consequent interruption of equestrian
activities [1,2]. EI is usually a self-limiting disease characterized by pyrexia, coughing and nasal
discharge [3]. Two subtypes of influenza A virus are known to infect horses, the H7N7 and the
H3N8. The H7N7 was identified in 1956 during an outbreak of respiratory disease in horses in
Czechoslovakia [4], and the H3N8 subtype was first detected in 1963 during a major epizootic
of respiratory disease in horses in Florida, United States (USA) [5,6]. Both subtypes of viruses
co-circulated for around 25 years; however, the H7N7 has not been isolated since 1979 and is
considered to be extinct [7], and since that time, all outbreaks of EI worldwide have been caused by
the H3N8 subtype.
Phylogenetic analysis of the equine influenza virus (EIV) haemagglutinin (HA) gene revealed
that the H3N8 EIV evolved as a single lineage for at least two decades [8] and diverged during the
mid-1980s, into the American and the European lineages, named according to the geographic origin of
the isolates [9,10]. Subsequently, strains within the American lineage diverged into South American,
Kentucky and Florida sub-lineages [11]. Nowadays, the Florida sub-lineage is predominant and has
evolved into two antigenically different clades: Florida clade 1 and Florida clade 2 [9]. Florida clade 1
strains have been isolated in North America since 2003 [9] and have been associated with EI outbreaks
in South Africa, Japan, Australia, Europe, Dubai and South America [1,12–17]. Florida clade 2
predominates in Europe, but has been also identified in some countries of Asia [18–20]. In addition
to this evolutionary pattern, in a genome-scale analysis, Murcia et al. described that, according to
the H3N8 EIV HA gene characteristics, 12 phylogenetically distinct clades (including Florida clade 1
and Florida clade 2) could be distinguished, each of them comprised by a group of viruses from a
particular geographical region and sharing a common ancestor [21].
In South America, the first reported EI outbreak occurred in Chile in 1963 due to EIV the H3N8
infection [22,23]; a further occurrence, in 1977, was caused by the H7N7 subtype infection [24].
The H3N8 EIV re-emerged in Chile in several outbreaks that occurred in 1985 and 1992 [25,26].
Another episode of EI, which affected both vaccinated and unvaccinated horses, occurred in 2006,
caused by a virus belonging to the H3N8 American lineage. The last reported outbreak of EI in Chile
was in 2012 [27].
In Brazil, there has been evidence of EIV circulation since 1963 (A/eq/SaoPaulo/6/1963, GenBank
accession number CY032293). Subsequent outbreaks of EIV occurred in 1969, 1976, 1986 and 1988 [28].
An extensive onset of acute respiratory disease in horses in 2012 was the last reported occurrence of EI
in this country [29].
Regarding the EI situation in Uruguay, the extensive outbreak occurred in 2012 was the only one
reported [16]. Nevertheless, previous evidence of the circulation of the virus is the HA gene nucleotide
sequences of two strains available at the GenBank database, the H3N8, A/eq/Uruguay/1/1963
(GenBank accession number CY032421) and the H7N7, A/eq/Uruguay/1063/1976 (GenBank accession
number CY036887).
With respect to the EI in Argentina, the first reported outbreak was in 1976 and the virus
belonged to the H7N7 subtype [30]. Since then, all the reported EI outbreaks have been caused
by the H3N8 subtype infection. The first detection occurred in the summer of 1985–1986, and is
described as one of the major outbreaks of EI due to the rapid spread of the virus all across the
country [31]. In 1993, a new episode of acute respiratory disease with high morbidity occurred among
thoroughbred horses in Palermo’s and San Isidro’s racecourses [10,32]. Sporadic H3N8 EI virus
incursions, with only a few horses involved, took place between 1994 and 2001 [11]. In 2005, EI arose
among horses stabled in a jumping club in Buenos Aires city, which had temporarily received horses
from Chile; the morbidity was low, not exceeding 10% of the horse population, and no cases outside
this location were reported [33]. All the EIVs identified between 1993 and 2005 were grouped within
the South American sub-lineage of the American lineage [11,33]. The last extensive outbreak of EI
registered in Argentina was in 2012 [16].
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The HA, one of the surface glycoproteins of the EIV, is the primary target of the protective
immune response [34]. The HA1 domain contains the major neutralizing antibody binding sites
identified from A to E [10,35]; if sufficient changes occur at these antigenic sites, the virus may evade
antibody neutralization [9]. Vaccines provide protection through the stimulation of antibody response,
especially against the HA glycoprotein [1,36], and vaccination plays a major role in controlling infection
and disease, particularly for horses that travel widely, intermingle with other horses or take part
in sports events [37]. Hence, the HA gene segment is of major importance and is the focus for
EIV surveillance [34]. The World Organization for Animal Health OIE Expert Surveillance Panel
(ESP) reviews the genetic, antigenic and epidemiological information of EI field outbreaks occurring
worldwide, in order to evaluate the vaccine effectiveness and elaborate recommendations to ensure
that the vaccines contain epidemiologically relevant strains [36].
In spite of the fact that viral surveillance and molecular descriptions have been performed on EIV,
no studies have analyzed the origin and the spatio-temporal phylodynamics of EIV in South America.
Thus, the aim of this work was to describe the molecular characteristics of the H3N8 EIV detected in
South America since its first identification, to infer the potential source of infections and to study its
demographic and phylogeographic patterns.
2. Results
2.1. Phylogenetic Analysis
EIV HA gene phylogenetic analyses were carried out with two different data sets: (a) partial HA1
and (b) complete HA nucleotide sequence gene. The topology of the trees obtained with maximum
likelihood (ML) was similar for both data sets (Figures S1 and S2). In addition, the time-scaled
maximum clade credibility (MCC) tree inferred by Bayesian coalescent analysis also displayed a similar
phylogenetic pattern (Figure 1) [38]. The resulting trees grouped all the viruses included in this study
into five well-supported clusters: Pre-divergent, Eurasian, American and Florida clade 1 and Florida
clade 2 sub-lineages (Figure 1, Figures S1 and S2). Following the criteria introduced by Murcia,
the twelve described different clades could also be distinguished in the trees obtained with the
complete HA date set [21]. However, three of the twelve groups (VI, VII and IX) were not observed
in the ML tree obtained with the partial HA data set, probably due to a lower phylogenetic signal
in the partial HA data set compared to the complete HA data set. Moreover, two additional clades,
called South America clade 1 and South American clade 2, were found in all the trees. Correlating,
isolates from Groups I to VIII belong to the Pre-divergent lineage, whereas Group IX and X belong to
the American and the Eurasian lineage, respectively.
All the H3N8 EIVs detected in South America were grouped into five monophyletic clades,
sustained by high support values (Figure 1, Figures S1 and S2). As previously described by
Murcia et al. [21], Group I is made up of strains detected in Brazil in 1963 and 1969 (n = 2),
and Group VIII of strains from Argentina (n = 1), Chile (n = 1) and interestingly, from USA (n = 1)
in 1985; these two groups were included in the Pre-divergent lineage. The EIV detected from 1993
to 1996 was grouped in the South American clade 1, which is composed only of Argentinian strains
(n = 6). The EIV identified between 1997 and 2006 belonged to the South American clade 2, grouping
strains detected in Argentina in 1997, 2001, 2004 and 2005 (n = 8) and in Chile in 2006 (n = 1). The South
American clades 1 and 2 were included in the American lineage constituting two separate groups,
independent from Murcia’s Group X. The EIV detected in Chile (n = 1), Brazil, (n = 1), Uruguay (n = 1)
and Argentina (n = 6) in 2012 belonged to the Florida clade 1 lineage (Figure 1, Figures S1 and S2).
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and South American clade 2, 1997. As for the viruses detected in South America in 2012, which 
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Table 1. Estimated time of the most recent common ancestor (tMRCA) for the five clades detected in
South America by Bayesian Coalescent analysis.
Clade Period tMRCA (HPD 95%) *
Group I 1963–1969 1962 (1961–1963)
Group VIII 1985 1984 (1983–1984)
South American Clade 1 1993–1996 1992 (1992–1993)
South American Clade 2 1997–2005 1997 (1996–1997)
Florida Clade 1 2012 2011 (2011–2012)
* HPD95%: Highest posterior density interval (95%).
In addition, the geographic spread pattern of the H3N8 EIV in South America was studied.
The most probable ancestral locations of different groups were estimated and are represented in
different colors in the MCC tree (Figure 1). Particularly, despite the fact that the analysis estimated
Brazil as the most probable ancestral location of the strains belonging to Group I (p = 0.98), the location
of the ancestral virus originating this group could not be defined with certainty. For Group VIII,
the most probable origin appears to be USA (p = 0.97). The South American clade 1 EIV, identified
between 1993 and 1996, would derive from strains circulating in USA (p = 1). The most probable
ancestral location of South American clade 2 and Florida clade 1 was also USA, with high probabilities
(p = 0.98 and p = 0.97, respectively). In accordance with this observation, the South American clade 2
was closely related to A/eq/California/4537/97 and A/eq/Kentucky/1/94 strains, while Florida
clade 1 strains from South America were closely related to A/eq/Florida/146609/11 strain; these were
identified as probable ancestors of these groups.
To gain insight into the spatio-temporal dynamics of the viral diffusion process, the MCC tree
can be visualized over time (Figure 2). The earliest divergence events were observed from Uruguay
to USA and Brazil between 1963 and 1969. After that, in 1971, the virus spread from USA into Asia
and subsequently from Asia into Africa in 1972. In 1973, the H3N8 EIV entered from USA into France,
and during the next few years the virus has spread within the European continent. The first link from
USA to South America occurred between 1983 and 1985, when the virus spread into Argentina and
Chile. Later, the EIV spread from USA into South Africa in 1986, and circulated in Europe during
the period 1989 and 1992. A new entrance from USA into Africa occurred in 1991 and from Europe
into Asia in 1992. A second migration wave from USA to South America was inferred between 1991
and 1993, and the virus was identified in Argentina in 1993. A third migration link between USA
and South America was inferred in 1996 and after its introduction, the virus spread across Argentina
(A/eq/Argentine/E-433/1997) and Chile (A/equine/Lonquen/1/2006). Between 2002 and 2007,
new introductions from USA to Europe and Asia occurred, and subsequently from Asia into Europe.
The last migration link between USA and South America was observed in 2011, after which the virus
circulated in Uruguay, Argentina and Brazil (Figure 2).
In addition, demographic reconstruction revealed that genetic diversity has remained constant
between 1960 and 1970, followed by an abrupt drop in the early 1980s, and an increase and stabilization
from about 1990 onwards. In 2006, viral diversity shows a remarkable increase with a maximum
in 2007, and then a slight decrease from 2007 to 2009 followed by an abrupt decrease from then on
(Figure 3) [38].
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2.3. Amino Acid Alignment
The HA1 derived amino acid (aa) sequences from the South American strains were aligned with
the prototype and the inferred ancestor strains of each group (Figure 4 and Table 2).
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^TNNEQTKLYVQEL
^S ·  ·  · ·  · · · · I  · · S
^S ·  ·  · ·  · · · · ·  · · S
^S ·  ·  · ·  · · · · I  · · S
^SNQQQTELYIQES ^VTVSTKRSQQTIIPNIG ^RN ^VFQYEN  
^ · · NE  · · K· · · · · ·  ̂· · · · ·  · · ·  · · · · · · · · · ^ · ·  ̂· · · · · ·   
^ · · NE  · · K· · · · · ·  ̂· · · · ·  · · ·  · · · · · · · · · ^ · ·  ̂· · · · · ·   
^ · · NE  · · K· · · · · ·  ̂· · · · ·  · · ·  · · · · · · · · · ^ · ·  ̂· · · · · ·   
^ · · NE  · · K· · · · · ·  ̂· · · · ·  · · ·  · · · · · · · · · ^ · ·  ̂· · · · · ·   
^ · · NE  · · K· · · · · ·  ̂· · · · ·  · · ·  · · · · · · · · · ^ · ·  ̂· · · · · ·   
^ · ·  ·  ·  · · · · · · · · ·  ̂· · · · ·  · · ·  · · · · · · · · · ^ · ·  ̂· · · · · ·   
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^ · ·  · E  · · K· · · · · ·  ̂· · · · ·  · · ·  · · · ·V·  · · · ^ · ·  ̂· · · · · ·   
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Table 2. Amino acid substitution characterizing the South American groups.
ro Aa Substitution
Group I K50R; T131N; S149N; S265G; L431I; A476T; L496V
Group I and A/eq/Uruguay/1/1963 G82; R323; I347; G381
S uth American clade 1 N312K
South American clade 2 S92N
Florida clade 1 K-14A; M70V
Strains belonging to Group I wer compared with A/eq/Uruguay/1/1963, as the H3N8 EIV is
suggested to have originated in South America. Elev aa substitutions wer found, three of th m
at antigenic sites: K50R (site C), which is xclusive to this group, N159S (site B) and V 42I (site D).
Three additional a changes, all of them outside of antigenic sit s and exclusive to this group, were
observed: T131N, S149N and S265G. The remaining aa substitutions were: G6S, G7D, N291E, Q327R
I328L, which are lso found in other str ins. The strai detected i Sao Pa lo in 9 possesses
an additional aa substitution at the antigenic site B (N189D), which is unique to this strain. The aa G
and R at positions 82 and 323 respectively, are obser d i Group I and Uruguay/1/1963 ut ot in
other H3N8 EIV strains.
Compared with A/eq/Fontainebleau/79 (Pre-divergent prototype strain), the strains belonging
to Group VIII identified in South America presented s ven aa substitutions: T46I, A93T, R140K, V223I,
I267V, T187S and L199S, the last two at the ntigenic site B.
In comparison with A/eq/Newmarket/1/93 (American li eage prototyp strain), viruses within
the South American clade 1 carried four aa substitutions at the HA1, three of them at the antigenic
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site B: Q189N, Q190E and E193K. The remaining aa substitution, N312K, is present only in the strains
of this lineage. The South American clade 2 strains showed three aa substitutions; one of these
substitutions, I214V, is located at the antigenic site D and is also present in one of the possible ancestors,
A/eq/California/4537/97. The remaining aa changes are S92N, which is exclusive to this group,
and D104N. In addition to the described aa substitutions, the strains detected in 1999 possess the
two aa changes at antigenic site B, Q190E and E193K, which were also observed in strains from the
South American clade 1. The EIV strains detected between 2001 and 2006 have evolved with a new aa
change, Q190K, in the antigenic site B, which is also exclusive to this group. The strains detected in
2005 and 2006 possess an additional and distinctive aa change, V78I.
The aa substitutions presented in the Uruguayan, Brazilian and Argentinian strains detected in
2012, when compared with the Florida clade 1 prototype strain (A/eq/Ohio/01/03) are: G7D, R62K
(in antigenic site E), D104N, A138S and V223I, which are also present in the possible origin of the
group, A/eq/Florida/146609/11 strain. In addition, two different sub-populations can be recognized
among them, one with a substitution at K-14A at the predicted peptide signal sequence; and the
other one at K-14T also at the predicted peptide signal sequence and M70V, the latter being present
only in Argentinian strains. With the available data for the strain detected in Chile in 2012 (deduced
aa sequence from position 1 to 159), the same four aa substitutions can be observed. Except for
K-14A and M70V, the Florida clade 1 South American strains have the same aa substitutions as
A/eq/Florida/146609/11.
3. Discussion
Since 1963, the EIV H3N8 subtype has been the cause of numerous outbreaks of respiratory disease
in horses worldwide, including South American countries where the horse industry is highly significant.
In this study, comprehensive phylogenetic and phylodynamic analyses of the EIV South American
strains were carried out to study their diversification, to infer their origin and to estimate the dynamics
of their geographical spread. This information could contribute to a better understanding of the
epidemiology of the H3N8 EIV infections worldwide and particularly in South America, and could
also allow Animal Health Authorities to improve the preventive and control measures currently in use.
The spatio-temporal analysis demonstrated that the H3N8 EIV strains detected in different
outbreaks of acute respiratory disease in horses in South America were grouped into five well
supported monophyletic clades. As was previously described, Group I is the oldest clade, and is
made up of strains detected between 1963 and 1969 also grouped into the Pre-divergent lineage. It is
believed that EIV of the H3N8 subtype crossed the species barrier from birds in the early 1960s and
has subsequently spread worldwide [1,3,36,39]. It has been suggested that the H3N8 EIV subtype
originated in South America, since it was identified after the arrival of thoroughbred horses imported
from Argentina to Miami in 1963 [5,6]. Even though there are no reports of EIV circulation in Argentina
at that time, there is evidence of H3N8 EIV infection and disease in horses in Chile, Brazil and
Uruguay [22,23]. Group VIII, also in the Pre-divergent lineage, consists of strains circulating in
1985 [21], which comprise the first isolation of an H3N8 EIV in Argentina [31] and a reintroduction of
this virus in Chile, apparently after the entry of horses from Argentina [25,26]. Surprisingly, a strain
detected in USA in 1985 belonged to this group, which could be due, as in 1963, to subclinically infected
horses traveling from South America to USA. The South America clade 1, described by Lai in 2001 [11],
groups only Argentinian strains. This lineage circulated for a period of 3 years (between 1993 and
1996) and it has not been detected since that time. The South American clade 2, that was previously
reported by Miño et al. [33], includes Argentinian and Chilean EIV strains detected between 1997
and 2006, and it has been previously suggested that based on the close resemblance of the viruses,
it entered Chile from Argentina [22]. The South American clade 1 and 2 are clustered into the American
lineage. These clades are made up of strains that circulated exclusively in South America between 1993
and 2006; yet, the clades would have different ancestors. Finally, the causative virus of the multiple
large-scale outbreak of EI in 2012 in South America belongs to the Florida clade 1, and spread among
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several countries, yielding important economic losses [1,16,29]. In addition, the same virus was also
detected in Dubai in 2012, in an outbreak in a quarantine facility after the entry of a group of endurance
horses from Uruguay [1].
The phylogenetic patterns of EIVs identified in South America are consistent with previous
studies that show that viruses from the same lineage are usually isolated in a particular geographical
region [11,21]. Interestingly, the viruses of each clade detected in South America have circulated only
for a few years, with no evidence of reemergence. This could be interpreted as a consequence of the
development of wide population immunity due to natural infections and/or efficacious vaccination
programs. The polyphyletic behavior of the viruses causing the outbreaks of equine influenza, which
took place in South America between 1963 and 2012, seem to be due to the introduction of at least
four different viruses, probably through the movement of subclinically infected horses. These findings
are in agreement with previous consideration that incursion of the influenza virus into new equine
populations can occur through subclinically infected horses facilitated by short quarantine periods
when horses travel internationally for competitions or sales [10,34].
Although the complete HA data set included all the HA complete sequences available at the
Influenza Research Database (n = 144), the most related sequences of the Group I, Group VIII and
South America clade 1 could not be estimated. Possibly, the analysis of other genome segments could
bring up more information and help to estimate the most related strains of these old South American
viruses. Additionally, the spatial and temporal dynamics for the geographic spread provided more
information on the migration patterns of the H3N8 EIV. The ancestral location for Group I could not
be determined with confidence; this could be due to a possible biased sampling of the EIV H3N8
during that period for which few isolates were sequenced. Despite being unable to accurately infer
the possible ancestors for Group VIII and South America clade 1, migration links were established
from USA to South America, so there is a high probability of the former being the ancestral location of
these groups, as well as of South America clade 2 and Florida clade 1. In agreement with previous
reports [5,6], the discrete phylogeographic model suggested South America as the starting point of
the spread of the EIV H3N8. In the map, migration links were established repeatedly between North
and South America, which is consistent with the frequent movement of horses that exists between
USA and South America and vice versa. Thoroughbred shuttle stallions, for example, travel from
USA to South America every breeding season and several thoroughbred mares are bought for genetic
improvement every year; furthermore, polo horses travel from Argentina for the polo season in USA,
coming back to Argentina when the season is over. Additionally, the diffusion process also suggested
USA as an important primary origin for the spread of the EIV H3N8 into Asia and Europe. This is
consistent with a report of the first detection of this virus in Europe, in an important outbreak of EI in
Switzerland in 1965, which was considered a major transcontinental pandemic of the EIV H3N8 [21,40].
However, a sub notification of EIV outbreaks could exist in other countries that could act as important
spreaders of the virus. The tMRCA estimated for the five clades detected in South America suggests
that the ancestor strains had been circulating in the Northern hemisphere at least one year before their
effective circulation in South America, with the exception of Miami 63, that apparently moved from
South America to North America [5,6].
As an aid in the understanding of the evolutionary pathways and population dynamics of the
H3N8 EIV, a demographic reconstruction was used to examine the changes of the effective number
of viral population size. The relative genetic diversity observed between 1963 and 2008 was similar
to that previously described by Murcia et al. [21]. In our work, the analyzed time was extended
from 2008 onwards. Since 2006, an accelerated increase in the relative genetic diversity was observed,
with a peak in 2007, followed by an abrupt decline in 2009. The co-circulation of the South American
clade 2, Florida clade 1 and Florida clade 2 sub-lineages strains [41] could be the reason of the observed
increase in the relative genetic diversity. The decrease observed since 2009 could have resulted from the
introduction of the Florida clade 2 strain in the vaccines, as recommended by the ESP [42]. However,
not all the manufacturers have updated their vaccines to contain Florida clade 2 strain. For this reason,
Pathogens 2016, 5, 61 10 of 14
another possible explanation may be the lack of active surveillance in some regions of the globe, or the
lack of sequences being made publicly available. The limited viral diversity found in the H3N8 EIV
strains is noteworthy, and it was homologated to the one observed with Influenza B virus in humans,
with only two lineages circulating [11,34].
Multiple amino acid substitutions have occurred in the HA of the viruses detected in
South America since the first description in 1963. The strains belonging to the Group I, Group VIII,
South American clade 1 and South American clade 2, have aa changes at antigenic site B compared
with the prototype strains. This observation is important because the fact that antigenic site B is
positioned at the top of HA1 implies that aa changes occurring in this site could compromise the viral
antigenicity [43,44]. In addition, some amino acid substitutions such as N312K and S92N present in the
South American clade 1 and 2, respectively, seem to be exclusive to South American strains. These aas
could be hence used as molecular markers to identify the reemergence of those viruses in the future.
On the contrary, no aa changes in the antigenic site B were observed in Florida clade 1 strains detected
in South America in 2012 when comparing it with the prototype strain A/eq/Ohio/2003. Nevertheless,
two subpopulations characterized by the aa substitutions K-14A and M70V (not in antigenic sites)
were observed indicating the occurrence of some degree of evolutionary change. These aa changes
are only found in South American strains, and M70V was observed only in Argentinian strains [16].
Nevertheless, these changes, outside the antigenic sites, do not imply the necessity to replace the
vaccine strain in regard to the Florida clade 1 strain, A/eq/Ohio/2003, recommended by the ESP.
This is additionally supported by the antigenic analysis carried out with 2012 Brazilian and Argentinian
isolates, that showed a good recognition by sera raised against other members of Florida clade 1 [16,29].
It is important to highlight that at the time of the last outbreak of EI in South America, the vaccines
on the market were not in line with the ESP recommendations; fortunately, after the outbreak many
vaccine manufacturers in Uruguay and Argentina updated their vaccine strains [16,29].
4. Experimental Section
4.1. HA Gene Sequencing
The complete HA nucleotide sequence data of 19 viruses detected in different outbreaks of EI
in Argentina during the period 1993 and 2012, and one strain detected in Uruguay in 2012, were
obtained (Table S1). The sequence data of 13 of these viruses were derived from RNA extracted
from nasopharyngeal swabs; the remaining 7 viruses (A/eq/Argentine/E131/1994, A/eq/Argentine/
E226/1995, A/eq/Argentine/E433/1997, A/eq/Argentine/E652/1999, A/eq/Argentine/E750/1999,
A/eq/Argentine/E1134-7/2001 and A/eq/Argentine/E6189-3/2005) required amplification in
embryonated hen’s eggs prior to sequencing.
The complete HA gene was amplified in two separate reactions by the OneStep RT-PCR kit
(Qiagen) using primers previously described by Gildea et al. [12]. The PCR products were purified
using the ExoStar (Illustra™, GE Healthcare UK Limited, Amersham, UK), according to manufacturer’s
recommendations, and sequenced by the “Unidad de Genómica, Instituto de Biotecnología,
INTA, Hurlingham”.
4.2. Sequence Analysis and Phylogenetic Trees
The obtained HA nucleotide sequences were edited with the BioEdit software v7.0.9.0 [45] and
were aligned using ClustalW in the software package of BioEdit, along with 144 reference HA complete
sequences (complete HA data set) available at the Influenza Research database (IRD) up to January 2015
and one sequence from Brazil obtained from the GISAID EpiFlu™ Database. In addition, a partial
HA1 nucleotide sequence (from position 52 to 545) from a strain detected in Chile in 2012 available at
the IRD, was also analyzed in the partial HA1 data set (Table S2).
Phylogenetic trees for partial HA1 and complete HA nucleotide sequences were inferred by
the maximum likelihood (ML) method using PhyML v3.1 software [46]. The best fit evolutionary
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models of nucleotide substitution were estimated according to the Akaike Information Criterion
(AIC) statistics obtained with the jModelTest v2.1.6 software [47]. Branch connecting sequence
A/equine/Uruguay/1/1963 detected in Uruguay in 1963 with the others was selected for rooting the
phylogenetic trees inferred from both data sets.
4.3. Phylodynamic Analysis
The nucleotide sequences including the information about location and the year of isolation from
the complete HA data set were introduced in the Bayesian coalescent analysis to estimate the time of the
most recent common ancestor (tMRCA), the population dynamics and the spatio-temporal diffusion
process. The analysis was carried out using the best fit evolutionary model of nucleotide substitution
(see above), the Bayesian Skyline Plot (BSP) model and the relaxed uncorrelated lognormal molecular
clock. A uniform prior to nucleotide substitution rate from 1 × 10−3 to 3 × 10−3 s/s/year was used to
carry out the analysis, which included the nucleotide substitution rate for HA gene of the EIV H3N8
previously calculated by Murcia et al. [21], corresponding to 1.7 × 10−3 s/s/year. To infer the ancestor
location and viral migration events, we grouped the H3N8 isolates into 26 states (countries) using the
discrete phylogeographic asymmetric model implemented in BEAST v1.8.3 software [48], which uses a
continuous time Markov Chain (CTMC) over discrete sampling locations and allows different rates of
diffusion between each pair of locations [49] Analyses were run using BEAGLE library [50,51] at the
CIPRES Science Gateway server [52]. The convergence of the parameters to a stationary distribution
was assessed with the TRACER v1.6 software [53]. Two independent analyses were performed and
results were combined. The trees were summarized in a maximum clade credibility (MCC) tree with
temporal and spatial annotation using the Tree Annotator v1.8.3 software after discarding the burn-in
samples. To visualize the geographic migration of the virus over the time, a keyhole markup language
(KML) file was generated using SpreaD3 v0.9.6 [54], which can be visualized via Google Earth V.
Monophyly was constrained for all sequences except for sequence A/eq/Uruguay/1/1963 detected in
Uruguay in 1963.
4.4. Amino Acid Analysis
The deduced amino acid sequences of HA1 were aligned with representative strains and the most
related sequences of each group. Alignments were analyzed using the BioEdit v7.0.9.0 software [45].
5. Conclusions
As a conclusion, EIV outbreaks that have taken place in South American countries were caused
by at least four different and independent introductions of the virus, presumably brought in through
the international movement of horses. Afterwards, these viruses circulated and induced outbreaks
of acute respiratory disease at a regional level, as the exchange of horses for competition amongst
South American countries is extremely frequent. Unfortunately, there is no information available
related to EIV infections in other South American countries; thus, we may infer that either the
disease has not occurred, or there are no surveillance programs, or there is an unavailability of
diagnostic laboratories or a sub-notification of EIV outbreaks, or a combination of these. Finally,
taking into account that the spread of EIV worldwide is facilitated by the international movement of
horses, adequate epidemiological surveillance programs, appropriate quarantine procedures and the
maintenance of high levels of population immunity through vaccination with updated and efficacious
vaccines, are critical aspects in the control of EI.
Supplementary Materials: The following are available online at www.mdpi.com/2076-0817/5/4/61/s1,
Figure S1: Maximum likelihood phylogenetic tree for the Partial HA 1 gene. Figure S2: Maximum likelihood
phylogenetic tree for the Complete HA gene. Table S1: Outbreaks of EIV in Argentina between 1993 and 2012.
Table S2: Equine influenza virus included in Phylogenetic and Coalescent analysis.
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